Subscribe to Newsletter

Advanced Medicine

Discovery & Development Advanced Medicine

Stem Cell Research and Treating Radiation Exposure

| Rob Coker | 3 min read

Researchers demonstrate how extracellular vesicles derived from mesenchymal stem cells can increase survival chances.

Manufacture Advanced Medicine

Kite, CAR Ts, and Access for Patients

| Stephanie Vine | 9 min read

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

Business & Regulation Trends & Forecasts

This Week’s Biopharma News: Roche’s $50 Billion Investment in the US and More

| 4 min read

Our latest news roundup reports on Roche’s US investment, a lawsuit against Vertex Pharmaceuticals, and more.

Manufacture Facilities

FUJIFILM Diosynth and Regeneron Sign 10-Year, $3 Billion Manufacturing Agreement

| Stephanie Vine | 2 min read

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Manufacture Advanced Medicine

Advancing AAV Manufacturing Quality

| Efrain Guzman | 3 min read

Overcoming the limitations of the triple plasmid transient transfection method for AAV manufacturing.

Discovery & Development Drug Discovery

Rewards in the Real World: Sitting Down With Igor Fisch

| 4 min read

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.

Manufacture Advanced Medicine

Cell Therapy: Getting GMP Right

| Stephanie Vine | 2 min read

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

Manufacture Advanced Medicine

Coming Soon: the Power List

| Rob Coker | 2 min read

The 2025 Power List will be available soon!

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

Business & Regulation Business Practice

The Trump Effect on Cell and Gene: Science versus Shockwaves

| 9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track


Latest White Papers

How to Improve the Capturing of Antibody Fragments

| Contributed by Tosoh

Accelerate innovation and manufacturing to better serve patients

| Contributed by GenScript Probio

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register